NEW PROBIOTICS USEFUL FOR ERADICATING HELICOBACTERIA PYLORIS INFECTION

CY1126238T1Undetermined Publication Date: 2026-07-31DACF SRL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CY20231100463T
Authority / Receiving Office
CY · CY
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-10-24
Filing Date
2023-09-06
Publication Date
2026-07-31
Estimated Expiration
2043-09-06
Patent Text Reader

Abstract

New probiotic clones have emerged that have enhanced activity against Helicobacter pylori infection. The new clones are derived from selected strains of Lactobacillus acidophilus and Bifidobacterium animalis lactis sp. They are advantageously insensitive to antibiotics currently used to treat Helicobacter pylori infection, which makes them ideal for co-therapy with said antibiotics in the eradication of Helicobacter pylori infection. Synergistic effects of combinations between the present probiotics and their strong adjuvant effect on the action of antibiotics on Helicobacter pylori are reported herein.
Need to check novelty before this filing date? Find Prior Art